Summary
Australia's Therapeutic Goods Administration (TGA) has issued a warning after a patient suffered an oesophagus tear from using a counterfeit version of the experimental weight loss drug retatrutide. The TGA emphasized that retatrutide is not approved for sale or prescription in Australia or overseas.